Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 720 matches for

An internationally recognised centre of excellence for biomedical and clinical research and teaching

New study reveals link between head injuries and viruses in Alzheimer's Disease

Researchers from Oxford’s Institute of Population Ageing and the University of Manchester, and Tufts University have found that head injuries, such as those induced in sports and the military, may re-awaken dormant viruses in the brain, triggering the onset of conditions including Alzheimer’s Disease and dementia

Oxford researchers develop blood test to enable early detection of multiple cancers

Oxford University researchers have unveiled a new blood test – powered by machine learning – which shows real promise in detecting multiple types of cancer in their earliest stages, when the disease is hardest to detect.

Umbrella review of traumatic brain injury research

Lead author Maya Ogonah outlines the findings from her research into traumatic brain injuries which has been published in the journal Nature Mental Health.

New study reveals the COVID-19 pandemic’s impact on other causes of death

An international study involving researchers at the Leverhulme Centre for Demographic Science has found significant effects of the COVID-19 pandemic on many causes of death across 24 countries.

Radical rethink of mental health support for adolescents needed – new study

Young people have given important insights into what mental health support they prefer and what does not work for them or meet their needs, as part of a major new study of thousands of adolescents.

A way to test the ability of red blood cells to deliver oxygen by measuring their shape

Scientists have developed a way of assessing the ability of red blood cells to deliver oxygen by measuring their shape. This test could improve specialist transplant and transfusion practice as well as blood banking. The research is now published open access in eBioMedicine – part of the Lancet Discovery Science.

Oxford study identifies the most effective treatments for ADHD in adults

Atomoxetine and a class of drug known as stimulants are the most effective treatments in the management of attention deficit hyperactivity disorder (ADHD) symptoms in adults, according to a new study.

Christmas Case Study

Research from the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) may have had an unanticipated secondary effect by saving Christmas.

The genetic basis of fertility, family and longevity

A new review by researchers from Oxford Population Health and the University of Iceland, published in Nature Aging, reveals how your DNA shapes reproductive health, fertility, and even life expectancy.

Alethiomics – using Artemis to hunt down blood cancers

Spin-out company Alethiomics, focused on the development of innovative treatments for blood cancers, is Oxford through-and-through. Founded by Clinician Scientists who run neighbouring laboratories at the University’s MRC Weatherall Institute of Molecular Medicine, seed financed by Oxford Science Enterprises and located at the BioEscalator, the company’s early years have been immersed in the Oxford innovation ecosystem.

Oxford and partners lead on two new MRC Centres to create cutting-edge gene therapies

Oxford University researchers are to lead and co-lead on two MRC research centres, which are being launched to develop new advanced treatments for currently untreatable diseases.

First vaccine against blood-stage malaria is well-tolerated and offers effective protection

The results of a clinical trial into a new malaria vaccine candidate (RH5.1/Matrix-MTM) show it is well-tolerated and offers effective protection against the blood-stage of the disease - the first inoculation to do so.

Wearable devices can help predict five year risk of falls for people with Parkinson’s Disease

A new study from the University of Oxford demonstrates how clinicians could use data to predict the risk of falls in people with Parkinson’s Disease (PD) to help improve effective longer term care planning.

Predicting Response to Rectal Cancer Treatment through the S:CORT consortium

Recent research from the S:CORT team spanning three publications has identified key biomarkers and treatment strategies that predict and enhance effectiveness of radiotherapy in rectal cancer treatment.

Department of Pharmacology research leads to FDA approval for new NPC treatment

A Department of Pharmacology start-up company has received approval from the US Food and Drug Administration (FDA) for a new treatment for the rare lysosomal storage disorder Niemann-Pick Disease Type C (NPC) in both adults and children.

Renewal of the Novo Nordisk – University of Oxford Fellowship Programme

Leading global healthcare company Novo Nordisk has deepened its partnership with the University of Oxford by announcing £18.5 million of funding for a further 20 Postdoctoral Fellows in this prestigious scientific research programme, over the next nine years. This expanded collaboration also introduces an innovative ‘Springboard Fellowship’, which offers selected fellows an extra two years of funding to further advance their research and professional development.

Study of menstrual tracking app usage highlights potential role in improving access to reproductive health services

A new study by researchers in the UK and Denmark, published in Digital Health, provides the first publicly accessible analysis of global downloads for menstrual tracking apps.

Transformative treatments for children with fatal genetic lung diseases

AlveoGene, a company co-founded by two of our scientists, today moves closer to approval of its novel inhaled gene therapy for a rare deficiency which causes fatal respiratory distress syndrome in newborns.

University of Oxford unveils new vaccine development partnership

Oxford Cancer, the Oxford Vaccine Group and the Pandemic Sciences Institute have announced a new collaboration with Belgian Biotech Innovator, Univercells.

Improvements to children’s surgery to be identified with the help of the NHS DigiTrials participant recruitment service

Researchers at Oxford Population Health’s National Perinatal Epidemiology Unit and ten children’s surgical hospitals across England and Scotland will use a service provided by NHS DigiTrials to investigate whether care and outcomes could be improved for children who have six conditions that usually need complex surgery shortly after birth.

Load More